Synonym
Neoarsphenamine; Neo-I.C.I.; Neoarsfenamin
IUPAC/Chemical Name
Sulfoxylic acid, mono(((5-((3-amino-4-hydroxyphenyl)diarsenyl)-2-hydroxyphenyl)amino)methyl) ester, monosodium salt
InChi Key
CXFGBOZIEIIEIH-UHFFFAOYSA-M
InChi Code
InChI=1S/C13H14As2N2O4S.Na/c16-10-5-8(1-3-12(10)18)14-15-9-2-4-13(19)11(6-9)17-7-21-22-20;/h1-6,17-20H,7,16H2;/q;+1/p-1
SMILES Code
[O-]SOCNC1=CC(/[As]=[As]/C2=CC=C(O)C(N)=C2)=CC=C1O.[Na+]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
466.15
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Bernhardt M. Hoffman's drops: the technique of the concentrated neosalvarsan injection. Skinmed. 2015 Jan-Feb;13(1):65. PubMed PMID: 25842475.
2: Heynick F. The original 'magic bullet' is 100 years old - extra. Br J Psychiatry. 2009 Nov;195(5):456. doi: 10.1192/bjp.195.5.456. PubMed PMID: 19880937.
3: Calvo A. [Ehrlich and the "magic bullet" concept]. Rev Esp Quimioter. 2006 Mar;19(1):90-2. Spanish. PubMed PMID: 16688302.
4: Michel JC, de Thoisy B, Contamin H. Chemotherapy of haemobartonellosis in squirrel monkeys (Saimiri sciureus). J Med Primatol. 2000 Apr;29(2):85-7. PubMed PMID: 10950456.
5: Salgado M, Sans M, Forns X, Bruguera M, Castells A, Navasa M, Rodés J. [Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature]. Gastroenterol Hepatol. 1995 Mar;18(3):132-5. Review. Spanish. PubMed PMID: 7621289.
6: Clemmesen J. [On the existence of Neosalvarsan]. Ugeskr Laeger. 1993 May 24;155(21):1651-2. Danish. PubMed PMID: 8317006.
7: Hadani A, Guglielmone AA, Anziani OS, Tarablas H, Mangold A, Bermudez A, Castor JC, Gonzalez de Rios L. A case of apparent suppression of Anaplasma marginale infection by eperythrozoonosis (Eperythrozoon teganodes). Vet Parasitol. 1982 Feb;9(3-4):267-72. PubMed PMID: 6211820.
8: Purnell RE, Lewis D, Holman MR, Young ER. Investigations on a Babesia isolated from Scottish sheep. Parasitology. 1981 Oct;83(Pt 2):347-56. PubMed PMID: 7329723.
9: Moulder JE, Lo PS, Fischer JJ. Effect of actinomycin D and neoarsphenamine on tumor control and skin tolerance in the rat. Cancer Treat Rep. 1978 May;62(5):713-9. PubMed PMID: 148967.
10: Kligerman MM, Schulhof L. Sensitization of bacteria to x-ray by neoarsphenamine. Radiat Res. 1969 Sep;39(3):571-9. PubMed PMID: 4896771.
11: Kligerman MM, Löfgren S, Dean C. Sensitization of Micrococcus sodonensis to x radiation by neoarsphenamine in the presence of oxygen. Radiology. 1967 May;88(5):993-4. PubMed PMID: 4225867.
12: Frey JR, de Weck AL, Geleick H. Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. IV. Desensitization to NEO. Int Arch Allergy Appl Immunol. 1966;30(6):521-37. PubMed PMID: 4225359.
13: Frey JR, de Weck AL, Geleick H. Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. 3. Immunological tolerance to NEO. Int Arch Allergy Appl Immunol. 1966;30(5):428-45. PubMed PMID: 4225334.
14: Frey JR, de Weck AL, Geleick H. Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. I. Sensitization to NEO. Overall results and experiments on the skin testing technique. Int Arch Allergy Appl Immunol. 1966;30(3):288-312. PubMed PMID: 4224664.
15: Frey JR, de Weck AL, Geleick H. Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. II. Influence of various factors on sensitization to NEO. Int Arch Allergy Appl Immunol. 1966;30(4):385-404. PubMed PMID: 4224602.
16: SUZUKI T, FUKADA C. THE MECHANISM OF THE SEROTONIN RELEASING ACTION OF CONGO RED AND THE ROLE OF SEROTONIN IN COLLOID SHOCK. Jpn J Pharmacol. 1964 Sep;14:363-74. PubMed PMID: 14265200.
17: TERRIER G. [TOPICAL TREATMENT OF SOME PHARYNGEAL LESIONS WITH NEOARSPHENAMINE (COLLUNOVAR-ATOMISEUR)]. Ther Umsch. 1964 Jul;21:272-4. French. PubMed PMID: 14248098.
18: WINTHER K. ["TICK ENCEPHALITIS", ARBORVIRUS INFECTION OF THE CENTRAL NERVOUS SYSTEM]. Ugeskr Laeger. 1964 Jun 11;126:831-4. Danish. PubMed PMID: 14161923.
19: FREY JR, GELEICK H, DEWECK A. IMMUNOLOGICAL TOLERANCE INDUCED IN ANIMALS PREVIOUSLY SENSITIZED TO SIMPLE CHEMICAL COMPOUNDS. Science. 1964 May 15;144(3620):853-4. PubMed PMID: 14149398.
20: STRAUSS WG, MANWARING JH. SPARGANOSIS. A NEW CASE IN THE UNITED STATES AND REVIEW OF THE LITERATURE. Dermatol Trop Ecol Geogr. 1964 Apr-Jun;28:73-8. PubMed PMID: 14201329.
